Doxazosin Tablets, USP, 4 mg, 1000 tablets per bottle, Rx only
Recalled by Unichem Pharmaceuticals USA Inc.
Class III — least serious
Using this product is not likely to cause health problems, but it breaks an FDA rule (for example, a labeling or packaging issue).
Unichem Pharmaceuticals USA Inc. has recalled Doxazosin Tablets, USP, 4 mg, 1000 tablets per bottle, Rx only, according to data published by the U.S. Food and Drug Administration (FDA). The recall was reported on February 18, 2026 and was initiated on January 21, 2026. It is classified as a Class III recall, which means using this product is not likely to cause health problems, but it breaks an FDA rule (for example, a labeling or packaging issue).
Below is a plain-English summary of what was recalled, why it was recalled, how to tell whether you have the affected product, and what steps you can take. For the complete and most current details, you can view the FDA record linked further down this page.
What was recalled?
This recall covers Doxazosin Tablets, USP, 4 mg, 1000 tablets per bottle, Rx only, with approximately 60,000 tablets affected. The company behind the recall is Unichem Pharmaceuticals USA Inc., based in East Brunswick, NJ. The FDA describes the product as: “Doxazosin Tablets, USP, 4 mg, 1000 tablets per bottle, Rx only, distributed by Unichem Pharmaceuticals (USA), Inc., 1 Tower Center Boulevard, Suite 2200, East Brunswick, NJ 08816 USA, manufactured by Unichem Laboratories Limited, Plot Number 15 to 18, Pilerne…”
Why was Doxazosin Tablets, USP, 4 mg, 1000 tablets per bottle, Rx only recalled?
According to the FDA, the stated reason for the recall is: “Tablets/Capsules Imprinted with Wrong ID.”
What should you do?
If you think you may have bought Doxazosin Tablets, USP, 4 mg, 1000 tablets per bottle, Rx only, compare it against the product description and identifying codes (Lot # GDSH25006, Exp Date: 08/2027) before using it. This recall is currently listed as ongoing.
The general guidance for a matching product is to stop using it and follow the instructions in the official FDA recall notice, which may include a repair, replacement, refund, or safe disposal. When in doubt, contact Unichem Pharmaceuticals USA Inc. or your local health authority.
About this recall
This recall was distributed in NJ. RecallRadar summarizes recall information from public FDA data to make it easier to understand. We are an independent service and are not affiliated with the FDA or any government agency, so please always refer to the official source for the authoritative record — and note the “last synced” date shown on this page, since recall details can change over time.
Full recall details
- Status
- Ongoing
- Date reported
- February 18, 2026
- Recall started
- January 21, 2026
- Distributed in
- NJ
What you can do
Check whether any product you have matches the description and codes above. If it does, stop using it and follow the instructions in the official recall notice. When in doubt, contact the company or your local health authority.
Quick answers
Why was Doxazosin Tablets, USP, 4 mg, 1000 tablets per bottle, Rx only recalled?+
According to the FDA: Tablets/Capsules Imprinted with Wrong ID
How serious is this recall?+
Class III — least serious. Using this product is not likely to cause health problems, but it breaks an FDA rule (for example, a labeling or packaging issue).
What should I do if I have Doxazosin Tablets, USP, 4 mg, 1000 tablets per bottle, Rx only?+
Compare your product against the description and identifying codes on this page. If it matches, stop using it and follow the instructions in the official recall notice — this usually means returning it for a refund or discarding it. When in doubt, contact the company or your local health authority.
Opens the U.S. Food and Drug Administration (FDA) data for this recall.
Recall number: D-0306-2026. Information last synced from the FDA on July 6, 2026.